Subsequently, by evaluation of an independent set of ESCC cases (the validation cohort), we concluded that the methylation status of HOXB2 and SEPT9 may be able to predict the presence of LNM. The gene discussed is HOXB2; the disease is esophageal squamous cell carcinoma.